Abdelghani M, et al . Experimental myositis: an optimised version of C-protein-induced myositis. RMD Open 2025;11:e004558. doi: 10.1136/rmdopen-2024–0 04 558 In this article, the abstract has been ...

The investigators suggest that IL-6 might be the culprit and could, therefore, be a candidate for future studies of myositis therapy. Therapeutic options for patients with idiopathic inflammatory ...

Myositis-specific autoantibodies (MSAs) are specific to patients with IIMs. Myositis-associated autoantibodies (MAAs) can also occur in dermatomyositis but is commonly seen in overlap with another ...

Amyloid β protein (Aβ) deposition in the brain is a hallmark of Alzheimer's disease (AD). The fibrillar form of Aβ is neurotoxic, although the mechanism of its toxicity is unknown. We showed th ...